Home » Topics » BioWorld Science, Infection

BioWorld Science, Infection
RSS

MetrioPharm plans to conduct a phase II study of MP-1032 in patients with COVID-19

Nov. 26, 2020

Equillium decides not to start phase III study of itolizumab for COVID-19

Nov. 26, 2020

Altimmune submits IND application with the FDA for phase I study of AdCOVID

Nov. 26, 2020

City of Hope begins phase I testing of investigational SARS-CoV-2 vaccine COH-04S1

Nov. 26, 2020

Treating Zika virus in a pregnant nonhuman primate model

Nov. 25, 2020

Phase III interim data reported on Sputnik V COVID-19 vaccine candidate

Nov. 25, 2020

Antimicrobial polymers AMP up fight against MDR bacteria

Nov. 25, 2020

First-in-human data presented for Plasmodium falciparum transmission-blocking MAb

Nov. 25, 2020

Humabs BioMed divulges antibodies targeting influenza A HA protein

Nov. 25, 2020

Capricor initiates dosing in phase II study of CAP-1002 in severe COVID-19

Nov. 25, 2020

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 6, 2026.
CINP 2026: Prenatal and adolescent stress shape brain vulnerability
BioWorld Science
Human biology is extraordinarily complex, and that sophistication emerges from the very beginning. During embryonic and fetal development, the organism’s...
Ontrack Therapeutics divulges compounds for neurodegenerative diseases
BioWorld Science
Ontrack Therapeutics Ltd. has reported new heterotricyclic compounds potentially useful for the treatment of neurodegenerative diseases.
Neuracle eyes Shanghai IPO as global BCI funding surges
BioWorld
Neuracle Medical Technology Co. Ltd. is seeking a Shanghai IPO that could make it China’s first publicly listed invasive brain-computer interface (BCI) company,...
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...